| CAS: | 1109276-89-2 | ||
| 分子式: | C21H24N4O4 | ||
| 分子量: | 396.44 | ||
| 英文名称: |
| ||
| 用途: | PF-04620110是一种口服有效的,选择性甘油二酯酰基转移酶-1(DGAT1)抑制剂,IC50为19 nM。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||
| P872562 | MACKLIN | PF-04620110 | 99% | 360元/5mg; 1172元/25mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| P794015 | MACKLIN | PF-04620110 | 10mM in DMSO | 557元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| PZ0207 | Sigma-Aldrich | PF-04620110 | ≥98% (HPLC) | 1179.67元/5 MG; 4776.54元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 PF-04620110 is known to regulate gut hormones. Inhibition of DGAT1 might serve as a good approach for the treatment of obesity and type 2 diabetes. DGAT1 inhibition might increase the oxidation of fatty acids, thus it is found to be protective against hepatic steatosis. 其他说明 This compound was developed by Pfizer for Lipid Signaling research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. 法律信息 Sold for research purposes under agreement from Pfizer Inc. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||